Contact: Rudolph A, Lutterschmidt
         (610-834-9600)

                           FOR IMMEDIATE RELEASE

                                                NOCOPI TECHNOLOGIES, INC.
                                                9C PORTLAND ROAD
                                                WEST CONSHOHOCKEN, PA 19428


NOCOPI TECHNOLOGIES, INC. ANNOUNCES NEW LICENSE SECURITY BUSINESS AGREEMENT WITH
CANDIDA STATIONERY IN NEW ZEALAND.

WEST CONSHOHOCKEN, PA. APRIL 13, 2005/PR NEWSWIRE
Today Michael A. Feinstein, M.D, Chairman and CEO of NOCOPI TECHNOLOGIES, INC.
(OTC BULLETIN BOARD: NNUP), a company dedicated to providing solutions for
product counterfeiting and diversion for national and international clients is
pleased to announce a new 2 year exclusive license of Nocopi's Patented Ink
Technology with CANDIDA STATIONERY in the arena of printed envelopes for the
direct mail industry in New Zealand and Australia. "We're very pleased to
initiate our business relationship with Candida Stationery and look forward to
yearly growth in the direct mail area," said Dr. Feinstein.

Candida Stationery, a 25 year old company headquartered in Auckland with offices
in Wellington, Christ Church and Sidney, manufactures a large range of stock
envelopes from a variety of papers and offers cost effective envelope solutions
utilizing some of the latest equipment and some of the most skilled people in
the Southern Hemisphere.

They are the leading envelope manufacturer in New Zealand and have one of the
largest manufacturing and print operations in Australasia.

Nocopi Technologies, Inc. is in the business of developing solutions against
counterfeiting, product diversion, document security, and authentication via
patented technologies (including invisible inks, color changing inks, reactive
thread and document security paper products.)

FORWARD-LOOKING INFORMATION

The foregoing contains forward-looking information within the meaning of The
Private Securities Litigation Act of 1995. Such forward-looking statements
involve certain risks and uncertainties. Actual results may differ materially
from such forward-looking statements (a summary of which may be found in the
Company's Annual Report on Form 10-KSB for the year ended December 31, 2004
under the caption "Uncertainties That May Affect the Company, its Operating
Results and Stock Price"). The Company does not undertake to publicly update or
revise its forward-looking statements even if experience or further changes make
it clear that any projected results (expressed or implied) will not be realized.